How a leading pharma company stayed updated with the latest solid tumors early stage advancements presented at AACR
The Challenge: Capturing the latest developments in the solid tumors space…
How we helped a Japanese innovator in cancer Dx estimate its market size and understand the future market dynamics
The challenge: Estimating the market size of innovative cancer Dx in Japan A…
How we helped a Top-10 Pharma optimize its asset's launch in the Breast Cancer space in EU5 and Japan.
The challenge: Understanding key competitor's activities in the rapidly…
How we helped a Top-20 Pharma competitively position its asset in the oncology biosimilars’ space.
The challenge: Strategically positioning an asset in the oncology biosimilars…
How our competitive simulation workshop helped a large pharma in precision oncology, develop its branding strategy for upcoming EU launches.
The Challenge: Formulating a brand strategy for new treatment launches in…
How we collaborated with a medium-sized pharma in the oncology biosimilars space so that they could make the most out of the ESMO conference.
The Challenge: Taking away key industry insights during a large international…
How a large pharma in the EU oncology space gained and used competitive intelligence to craft a defense against threats from generics.
The Challenge: Gaining Competitive Intelligence on upcoming generics…
How we helped two pharma companies assess their own and their competitors' social media during ESMO 2023 and ASCO 2023.
The Challenge: How to maximize the benefits of social media monitoring during…
How our benchmarking analysis contributed to a Hemato-Oncology company's sales and pricing strategy for specific agents.
The Challenge: Competitive benchmarking, including sales force and market…
How a large pharma in Hematology and Oncology space established and used competitive benchmarks across the US
The Challenge: Knowing field force performance against the competition A large…
From Scarcity to Sufficiency: Understanding and Resolving the Cancer Drug Shortage in the United States
The US has been struggling with a severe cancer drug shortage for several…
Multiple myeloma treatment: Why we still need novel scientific research.
Multiple myeloma (MM) is an incurable form of hematological cancer affecting…
